Pliant Therapeutics (PLRX) Amortizatization of Intangibles (2022 - 2024)
Pliant Therapeutics (PLRX) posted quarterly Amortizatization of Intangibles of -$1.0 million for Q3 2024, down 127.03% year-over-year from $3.7 million in Q4 2023, and down 780.95% quarter-over-quarter from $147000.0 in Q2 2024.
Pliant Therapeutics (PLRX) Amortizatization of Intangibles (2022 - 2024) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Amortizatization of Intangibles for 3 consecutive years, with -$1.0 million the latest figure, recorded in Q3 2024.
- In Q3 2024, Amortizatization of Intangibles fell 127.03% year-over-year to -$1.0 million; the TTM figure through Sep 2024 stood at $1.8 million (down 85.05% YoY), while the FY2022 annual figure was $1.8 million, up 243.11% from the prior year.
- Amortizatization of Intangibles fell to -$1.0 million in Q3 2024 per PLRX's latest filing, from $147000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $3.9 million in Q2 2023 and bottomed at -$1.1 million in Q1 2024.
- Historically, Amortizatization of Intangibles has averaged $1.0 million across 3 years, with a median of $427000.0 in 2022.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles soared 2397.08% — and 2024, when it plunged 142.22%.
- Pliant Therapeutics' Amortizatization of Intangibles stood at $1.5 million in 2022, then jumped by 140.14% to $3.7 million in 2023, then tumbled by 127.03% to -$1.0 million in 2024.
- Business Quant data shows PLRX's Amortizatization of Intangibles at -$1.0 million in Q3 2024, $147000.0 in Q2 2024, and -$1.1 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Pliant Therapeutics | 71.52 Mn | 71.52 Mn | - | 842,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -1.00 Mn |
| Sep 30, 2024 | -1.00 Mn |
| Jun 30, 2024 | 147,000.00 |
| Jun 30, 2024 | 147,000.00 |
| Mar 31, 2024 | -1.09 Mn |
| Mar 31, 2024 | -1.09 Mn |
| Sep 30, 2023 | 3.70 Mn |
| Sep 30, 2023 | 3.70 Mn |
| Jun 30, 2023 | 3.93 Mn |
| Jun 30, 2023 | 3.93 Mn |
| Mar 31, 2023 | 2.58 Mn |
| Mar 31, 2023 | 2.58 Mn |
| Dec 31, 2022 | 1.54 Mn |
| Dec 31, 2022 | 1.54 Mn |
| Sep 30, 2022 | 707,000.00 |
| Sep 30, 2022 | 707,000.00 |
| Jun 30, 2022 | -171,000.00 |
| Jun 30, 2022 | -171,000.00 |
| Mar 31, 2022 | -272,000.00 |
| Mar 31, 2022 | -272,000.00 |